Effect of Domperidone on the Nutrient Composition of Preterm Mother's Breast Milk

NCT00308334 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2009-06-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of domperidone (given to lactating mothers of very preterm infants) on the macronutrient composition of human milk.

Conditions

  • Low Breast Milk Supply

Interventions

DRUG

Domperidone

10 mg po TID X 14 days

DRUG

Placebo- Sugar pill

placebo po TID x 14 days

Sponsors & Collaborators

  • Canadian Nurses Foundation (CNF)

    collaborator OTHER
  • Dalhousie University

    collaborator OTHER
  • IWK Health Centre

    lead OTHER

Principal Investigators

  • Marsha L Campbell-Yeo, MN NNP-BC PhDc · IWK Health Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2007-12-31
Completion
2008-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00308334 on ClinicalTrials.gov